Clinical Oncology - Issue Supplementum 3/2015

6
Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia

V. Navrkalová, B. Kantorová, M. Jarošová, Š. Pospíšilová

16
Significance of Minimal Residual Disease in Chronic Lymphocytic Leukemia

M. Doubek

22
Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015

P. Obrtlíková, R. Urbanová

30
Therapeutic Options for „Slow‑ go“ Patients with Chronic Lymphocytic Leukemia

L. Smolej

39
Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations

D. Lysák, J. Schwarz

45
Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future

M. Špaček

50
News in the Supportive Care of Chronic Lymphocytic Leukemia

M. Brejcha

55
Malignant Lymphomas – Past, Present and Future

M. Trněný, P. Klener Jr., R. Pytlík

64
Diffuse Large B‑ cell Lymphoma –  Modern Dia­gnostics and Molecularly Targeted Treatment

R. Pytlík, M. Trněný

73
Follicular Lymphoma

K. Benešová, M. Trněný

80
Mantle Cell Lymphoma –  Cutting‑ edge Dia­gnostics and Treatment Approaches

P. Klener Jr., M. Trněný

87
Hodgkin´s Lymhoma – the Treatment Aproaches Development and Current Trends

J. Kořen, M. Trněný

95
Salvage Treatment and the Role of Transplantation in Lymphomas

D. Pohlreich, B. Vacková, R. Pytlík, M. Trnková, M. Trněný

105
Current Approaches in Cancer Immunotherapy

P. Otáhal, M. Trněný


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account